4th Quarter - Termination
DLA PIPER LLP (US) for GENENTECH USA, INC.
Firm
Client
Income
$50,000
Expenses
—
Terminated
Dec 31, 2022
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Legislative and regulatory policies affecting biotechnology including: pharmaceutical development; biodefense; and diagnostics. H.R. 8295, Labor/HHS/Education Appropriations for FY2023, provisions regarding pandemic response. H.R. 5801, HELP Copays Act.
Foreign entity interest: Roche Holdings, AG, interests are those of parent company.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES GREENWOOD | — |
| JAMIE ALEXEI GREGORIAN | — |
| ALEX PINSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.